Induction of Abortion
Conditions
Brief summary
The Patient are divided into 3 groups group 1 included 50 cases using misoprostol only. group 2 included also 50 cases in which using misoprostol with letrozole. Group3 included also 50 cases in which using misoprostol with Foleys catheter for termination of second trimesteric abortion between 14 and 24 weeks
Detailed description
Pregnant women were randomized into three equal groups: Group allocation was blindly randomized concealed by placement in numbered opaque sealed envelopes. These envelopes were kept in the labor ward and drawn in consecutive order: Group 'A (misoprostol only group): Pharmacological method for termination of second trimester missed abortion was done by given 200 microgram misoprostol (Misotac 200 microgram tablet, Sigma Pharmaceuticals, Egypt), in sublingual every four hours for a maximum of five doses. Group 'B'(misoprostol with letrozole group): The anti-estrogen action of letrozole has been show to be useful in pretreatment for termination of pregnancy ,in combination with misoprostol,women in the letrozole group received 15mg( letrozole2.5mg) on three successive day patient take doses of letrozole for daily oral three successive day at home by herself and forth day admitted to our hospital followed by sublingual misoprostol 200 microgram misoprostol (Misotac 200 microgram tablet, Sigma Pharmaceuticals, Egypt), every four hours for a maximum of five doses. Group 'C' (misoprotol with Foley's catheter group): Mechanical method for termination of second trimester missed abortion was done using the transcervical 16F Foley's catheter with 30 ml balloon capacity (Euromed for Medical Industries, Cairo, Egypt, under license of Kanglite, USA), inserted under aseptic conditions withsublingual misoprostol 200 microgram misoprostol (Misotac 200 microgram tablet, Sigma Pharmaceuticals, Egypt), every four hours for a maximum of five doses.
Interventions
DRUGMisoprostol
200 microgram misoprostol in sublingual every four hours for a maximum of five doses
DRUGLetrozole
15mg( letrozole 2.5mg) on three successive day
PROCEDUREFoley's catheter
transcervical 16F Foley's catheter with 30 ml balloon capacity inserted under aseptic conditions
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No
Inclusion criteria
* singleton pregnancy * gestational age between 14 and 24 weeks * Fetal death was confirmed by ultrasonic scan * Unfavorable cervix using Bishop score for cervical assessment with score less than 5 * Parity less than 5 * No uterine contractions
Exclusion criteria
* Previous uterine scar eg scar for cessarian section * Rupture of membranes * Chorioamnionitis * Placenta previa or low lying placenta. * Women with medical disease like DM, coagulopathy or genital infections. * Hypersensitivity or contraindications for receiving misoprostol, including:Maternal asthma.Sickle cell disease.Known hypersensitivity to prostaglandins.History of glaucoma
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| complete evacuation of uterus | 24 hours after treatment | clear endometrial line \< 4 mm in thickness |
Countries
Egypt
Contacts
Primary ContactAhmed maged
Backup Contactameer elsherief
Outcome results
None listed